← SynDRA
CMPD-1
SynDRA canonical compound SYN0058955 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | MAPK14 |
| Mechanism of action | P38 MAPK inhibitor |
All known targets
Mechanisms of action (all sources)
- MAPK14 INHIBITOR
- MAPKAPK2 INHIBITOR
Cross-references
Synonyms
- CMPD1
- MK2a Inhibitor
- MAPKAPK2a Inhibitor
- 4-[4-(2-fluorophenyl)phenyl]-N-(4-hydroxyphenyl)butanamide
- 4-(4-(2-fluorophenyl)phenyl)-N-(4-hydroxyphenyl)butanamide
- RefChem:159225
- DTXCID00415039
- 2'-FLUORO-N-(4-HYDROXYPHENYL)-[1,1'-BIPHENYL]-4-BUTANAMIDE
- IN1225
- SCHEMBL169905
- C22H20FNO2
- GTPL6009
- orb1308436
- SCHEMBL29729259
- CHEBI:92949
- GLXC-07118
- HMS3229K04
- HMS3268P13
- HMS3413K11
- HMS3677K11
- EX-A7609
- BDBM50411445
- MFCD08703098
- AKOS024456977
- CCG-206869
- SDCCGSBI-0086775.P003
- NCGC00092325-01
- DA-62426
- MS-25394
- HY-108643
- CS-0029377
- F77818
- T14988
- F869884
- BRD-K54095730-001-01-5
- BRD-K54095730-001-03-1
- 4-(2'-fluorobiphenyl-4-yl)-n-(4-hydroxyphenyl)-butyramide
- MK2a inhibitor
- MAPKAPK2a inhibitor
Look up CMPD-1 in the interactive SynDRA portal →